您的位置: 专家智库 > >

国家自然科学基金(81000702)

作品数:2 被引量:7H指数:2
相关作者:闫言更多>>
相关机构:北京协和医院更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 2篇中文期刊文章

领域

  • 2篇医药卫生

主题

  • 1篇止痒
  • 1篇止痒软膏
  • 1篇软膏
  • 1篇湿疹
  • 1篇胃苓汤
  • 1篇疗效
  • 1篇疗效观察
  • 1篇慢性
  • 1篇慢性湿疹
  • 1篇NIH3T3
  • 1篇APOPTO...
  • 1篇EXPRES...
  • 1篇MATRIX...
  • 1篇除湿
  • 1篇除湿胃苓汤
  • 1篇RECEPT...
  • 1篇INVOLV...

机构

  • 1篇北京协和医院

作者

  • 1篇闫言

传媒

  • 1篇Chines...
  • 1篇中国医药导报

年份

  • 2篇2013
2 条 记 录,以下是 1-2
排序方式:
Receptor interacting protein 1 involved in ultraviolet B induced NIH3T3 cell apoptosis through expression of matrix metalloproteinases and reactive oxygen species production被引量:2
2013年
Background Receptor interacting protein 1 (RIP1), which plays a key role in apoptosis, cell survival and programmed cell necrosis, is one of the most important proteins in the RIP family. The purpose of this study was to investigate the roles of RIP1 in the apoptosis, the generation of reactive oxygen species (ROS) and the expression of matrix metalloproteinases (MMPs) induced by ultraviolet B (UVB) in fibroblasts. Methods siRNA targeting RIP1 was used to silence RIP1 expression in the NIH3T3 fibroblasts. The mRNA and protein levels of MMP-1 and MMP-3, caspase-3 and -8 activities, and ROS activities were determined by reverse transcriptasequantitative polymerase chain reaction (RT-qPCR), immunoblotting, caspase activity assay, immunofiuorescence, and flow cytometry. Results The mRNA and protein expressions of MMP-1 and MMP-3 were significantly increased in RIP1 deficient NIH3T3 cells at 24 hours after UVB treatment. At 24 hours after exposure to UVB, RIP1 deficient NIH3T3 cells presented apoptotic morphology, and the apoptosis rate was significantly increased accompanied by pronounced increase in caspase-8 and -3 activities. ROS production was inhibited by UVB at 12 hours in RIP1 deficient NIH3T3 cells. Conclusion RIP1 is involved in NIH3T3 cell damage induced by UVB via participating in the apoptosis, expression of MMPs and ROS production.
YAN YanLI LiXU Hao-xiangPENG Shi-guang,QU TaoWANG Bao-xi
关键词:APOPTOSIS
除湿胃苓汤联合除湿止痒软膏治疗慢性湿疹疗效观察被引量:5
2013年
目的评价除湿胃苓汤联合除湿止痒软膏治疗慢性湿疹的临床疗效。方法选择2011年10月~2012年10月广西壮族自治区大新县人民医院306例慢性湿疹患者,分为治疗组(164例)和对照组(142例),治疗组患者给予口服除湿胃苓汤,每日500mL分2次服用,同时外涂除湿止痒软膏,每日3次,连续治疗4周。对照组口服盐酸依匹斯汀胶囊,每日10mg,联合复方氟米松软膏外用,每日2次,连续治疗4周。结果治疗组痊愈率、显效率、有效率和无效率分别为76.2%、12.8%、4.2%和6.7%,总有效率为93.2%。对照组痊愈率、显效率、有效率和无效率分别为53.5%、16.1%、7.7%和22.5%,总有效率为77.4%。两组总有效率比较差异有统计学意义(Х^2=21.711,P=0.000)。治疗组无不良反应,对照组有4例发生不良反应(Х^2=4.684,P=0.030)。两组复发率比较差异有统计学意义(Х^2=8.543,P=0.003),对照组复发率明显高于治疗组。结论除湿胃苓汤联合除湿止痒软膏治疗慢性湿疹是安全、有效的。
张振汉闫言
关键词:慢性湿疹除湿胃苓汤
共1页<1>
聚类工具0